Form 13-F position report

MEDTRONIC PLC

Reported by EQUITY INVESTMENT CORP

MDT CUSIP G5960L103 Manager CIK 0001685771

Reported 2,066,121 shares, down 4,461 (0.2%) from the prior quarter.

Reported value 10.1%; share count -0.2% vs. the prior quarter.

Reduced
% of reported 13F value 3.36% This manager · Q3 2026
Shares 2,066,121 Quarter-end amount reported
Reported value $178,285,581 Fair value at quarter end
Consecutive quarters held 16 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 78338107
2023-03-31 84853114
2023-06-30 91698797
2023-09-30 82169863
2023-12-31 110478110
2024-03-31 122403812
2024-06-30 113962362
2024-09-30 131304087
2024-12-31 116838447
2025-03-31 130923401
2025-06-30 130579210
2025-09-30 144734275
2025-12-31 146223738
2026-03-31 138525590
2026-06-30 161981619
2026-09-30 178285581

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for MEDTRONIC PLC held by EQUITY INVESTMENT CORP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 2,066,121 -4,461 (-0.2%) 3.36% $178,285,581 2026-11-04
Q2 2026 Added 2,070,582 +471,902 (29.5%) 3.09% $161,981,619 2026-08-07
Q1 2026 Added 1,598,680 +76,467 (5.0%) 2.71% $138,525,590 2026-05-04
Q4 2025 Added 1,522,213 +2,534 (0.2%) 2.95% $146,223,738 2026-02-12
Q3 2025 Added 1,519,679 +21,696 (1.4%) 3.03% $144,734,275 2025-11-05
Q2 2025 Added 1,497,983 +41,012 (2.8%) 2.86% $130,579,210 2025-08-06
Q1 2025 Reduced 1,456,971 -5,704 (-0.4%) 2.93% $130,923,401 2025-05-02
Q4 2024 Added 1,462,675 +4,227 (0.3%) 2.74% $116,838,447 2025-02-05
Q3 2024 Added 1,458,448 +10,571 (0.7%) 3.05% $131,304,087 2024-11-07
Q2 2024 Added 1,447,877 +43,358 (3.1%) 2.91% $113,962,362 2024-08-08
Q1 2024 Added 1,404,519 +63,440 (4.7%) 3.06% $122,403,812 2024-05-07
Q4 2023 Added 1,341,079 +292,459 (27.9%) 3.1% $110,478,110 2024-02-08
Q3 2023 Added 1,048,620 +7,771 (0.7%) 2.56% $82,169,863 2023-11-08
Q2 2023 Reduced 1,040,849 -11,658 (-1.1%) 2.84% $91,698,797 2023-08-03
Q1 2023 Added 1,052,507 +44,554 (4.4%) 2.78% $84,853,114 2023-05-04
Q4 2022 New 1,007,953 +1,007,953 (0.0%) 2.64% $78,338,107 2023-02-08
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2313 managers reported MEDTRONIC PLC for Q3 2026.

Managers reporting MEDTRONIC PLC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 118,770,885 +4,750,098 0.15% $10,248,739,689 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 83,752,662 -64,073 0.15% $7,227,017,204 3 qtrs
STATE STREET CORPORATION Added 65,987,354 +2,588,039 0.17% $5,741,305,775 47 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 34,302,943 +242,976 0.13% $2,960,000,951 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,879,777 +687,762 0.14% $2,654,207,843 47 qtrs
MASSACHUSETTS FINANCIAL SERVICES CO MA Reduced 18,092,316 -1,780,284 0.86% $2,555,233,164 47 qtrs
FRANKLIN RESOURCES INC Added 18,217,298 +666,315 0.4% $1,912,095,040 47 qtrs
JPMorgan Chase & Co Reduced 21,712,856 -6,071,615 0.1% $1,890,972,824 47 qtrs
Bank of America Corporation Reduced 20,689,531 -632,870 0.11% $1,785,299,618 47 qtrs
MORGAN STANLEY Reduced 19,222,514 -222,357 0.08% $1,658,710,956 47 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 04, 2026
Filing type
13F-HR
Position type
SHS

Voting authority reported

Sole
1,817,678
Shared
0
None
248,443

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.